依那普利 T1605
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
2 mg | 75847-73-3 | ¥126.00 | 询底价 |
5 mg | 75847-73-3 | ¥179.00 | 询底价 |
25 mg | 75847-73-3 | ¥385.00 | 询底价 |
10 mg | 75847-73-3 | ¥246.00 | 询底价 |
50 mg | 75847-73-3 | ¥552.00 | 询底价 |
100 mg | 75847-73-3 | ¥786.00 | 询底价 |
Product Introduction
Bioactivity
英文名: Enalapril
描述: Enalapril 是一种血管紧张素转换酶(ACE)抑制剂。
激酶实验: PDGF receptor kinase activity: PDGF receptor is immunoprecipitated from BALB/c 3T3 cell extracts with rabbit antiserum to the murine PDGF receptor for 2 hours on ice. Protein A-Sepharose beads are used to collect the antigen-antibody complexes. The immunoprecipitates are washed twice with TNET (50 mM Tris, pH 7.5, 140 mM NaCl, 5 mM EDTA, 1% Triton X-100), once with TNE (50 mM Tris, pH 7.5, 140 mM EDTA), and once with kinase buffer (20 mM Tris, pH 7.5,10 mM MgCl2). After stimulation with PDGF (50 ng/mL) for 10 minutes at 4 °C, different concentrations of drug are added to the reaction mixture. PDGF receptor kinase activity is determined by incubation with 10 μCi [7-33P]-ATP and l μM ATP for 10 minutes at 4 °C. Immune complexes are separated by SDS-PAGE on 7.5% gels.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: H2O : Soluble
DMSO : 55 mg/mL (146.1 mM)
关键字: ACE inhibitor | Enalapril | Antihypertensives | Inhibitor | inhibit | MK421 | MK 421 | Angiotensin-converting Enzyme (ACE)
相关产品: Candesartan Cilexetil | [Sar1, Ile8]-Angiotensin II acetate | Pratosartan | Ramipril | Moveltipril | TRV055 acetate | Alamandine TFA | Quinapril hydrochloride | Lisinopril dihydrate | Buloxibutid
相关库: FDA-Approved Drug Library | Drug Repurposing Compound Library | Approved Drug Library | Anti-Hypertension Compound Library | FDA-Approved & Pharmacopeia Drug Library | Membrane Protein-targeted Compound Library | Bioactive Compounds Library Max | Inhibitor Library | Bioactive Compound Library
依那普利 T1605信息由TargetMol中国为您提供,如您想了解更多关于依那普利 T1605报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途